Amundi Q4 2025: Europe’s asset-management giant ends the year with a $367.99B U.S. filing

Amundi’s year-end 13F landed with scale and a very familiar U.S. core

Amundi finished 2025Q4 with $367.99B in reported 13F AUM, a 73.00 WhaleScore, and a canonical snapshot of 500 positions. For a firm that describes itself as Europe’s leading asset manager, the most immediate signal in the U.S. filing is simple: the disclosed book got materially bigger into year-end, and the capital is concentrated in the same mega-cap names that dominated global equity leadership in 2025.

The top of the filing is led by NVDA at $22.60B, AAPL at $16.12B, and MSFT at $15.41B. They are followed by AMZN, GOOGL, TSLA, AVGO, META, GOOG, and LLY. Retail investors should read that not as a quirky stock-picking list, but as a map of where one of Europe’s biggest investment platforms is parking disclosed U.S. equity risk.

The upper book is huge, liquid, and benchmark-aware

Amundi’s top weights are large enough to matter but still measured in institutional terms. NVDA is 6.47% of the portfolio, AAPL is 4.62%, and MSFT is 4.41%. After that, the weight curve drops into the mid- to low-single digits: AMZN at 3.56%, GOOGL at 2.52%, TSLA at 2.50%, AVGO at 2.36%, META at 1.90%, GOOG at 1.60%, and LLY at 1.42%.

That shape matters. This filing does not read like a narrow activist campaign or a hedge fund built around one controversial thesis. It reads like a giant allocation engine leaning into liquid U.S. winners. The top 10 disclosed names account for 31.36% of the portfolio, leaving 68.64% spread across the rest of the book. That is concentrated enough to tell you what matters, but diversified enough to look like a scaled institutional portfolio rather than a trader’s diary.

The sharpest signal is the Q4 acceleration

Amundi’s disclosed 13F value moved from $311.14B in 2025Q3 to $367.99B in 2025Q4, a 18.3% quarter-over-quarter jump. The filing’s holdings count also moved up from 4786 to 5068. That matters because it shows year-end expansion in both disclosed value and line-item breadth after a steadier climb through the rest of 2025.

The eight-quarter path makes the move more obvious. Reported 13F AUM was $232.70B in 2024Q1, $260.88B in 2024Q2, $271.36B in 2024Q3, $287.59B in 2024Q4, $274.71B in 2025Q1, $289.69B in 2025Q2, $311.14B in 2025Q3, and then $367.99B in 2025Q4. For retail readers, that turns this filing from a static snapshot into a trend story: Amundi did not just stay big, it got a lot bigger into the final quarter.

The biggest tension: Amundi’s own market view called for diversification

There is a useful contradiction here. In its Global Investment Views - February 2025, Amundi said it preferred equal-weighted U.S. exposure over cap-weighted benchmarks and kept a neutral stance on U.S. equities because of tight valuations and concentration risk. Its 2025 Investment Outlook and Capital Market Assumptions 2025 made the same diversification case more broadly: look beyond U.S. mega-caps, add regional balance, and prepare for a riskier world.

Yet the disclosed 13F still ends the year led by the exact mega-cap complex everyone knows. That does not make the filing inconsistent. It makes it realistic. A 13F only shows long U.S.-listed equity exposure, not the full global allocation, not hedges, and not the rest of a multi-asset platform. But it does show where Amundi’s disclosed U.S. sleeve was largest at year-end, and that answer is unmistakably mega-cap tech and platform scale.

Corporate context explains why the U.S. sleeve matters right now

Amundi’s own corporate reporting gives that filing more context. The firm said 2025 net inflows reached +€88bn and group assets under management hit €2,380bn at year-end. Earlier in the year, Amundi said the Victory Capital partnership had closed on 1 April 2025, allowing it to offer more U.S. strategies. By year-end, the company said it had launched three new Victory Capital strategies in UCITS format for European and Asian clients.

That backdrop matters because it suggests the U.S. equity sleeve is not isolated from the group strategy. Amundi is a European giant, but it is actively broadening its U.S. product set while operating in a market where mega-cap liquidity still dominates benchmark exposure. The 13F cannot tell you everything about that push, but it does show the end state inside the disclosed U.S. book: bigger scale, bigger year-end value, and a top line still owned by the market’s largest platforms.

What retail investors should take away

• The filing got bigger fast. Amundi’s reported 13F AUM jumped from $311.14B to $367.99B in one quarter.
• Mega-cap leadership still rules the disclosed book. NVDA, AAPL, and MSFT are the top three lines, with AMZN, GOOGL, TSLA, and AVGO right behind them.
• The diversification story is not invalidated, but it is complicated. Amundi’s house research argues for broader exposure than cap-weighted U.S. benchmarks, yet the visible U.S. sleeve still clusters around the biggest names.
• Context is everything. A 13F is a partial lens into one region and one asset class. For Amundi, the more complete read-through is product expansion, inflow momentum, and how a European giant is managing U.S. exposure at scale.

Source links and further reading

• 13F Insight filer page for Amundi
• SEC company filings page for Amundi
• 13f.info manager page for Amundi
• Amundi corporate homepage
• Amundi 2025 4th quarter and annual results
• Amundi 2025 1st quarter results
• Amundi 2025-2028 strategic plan
• Amundi Global Investment Views - February 2025
• Amundi 2025 Investment Outlook
• Amundi Capital Market Assumptions 2025
• Amundi Asset Management US brochure via Morgan Stanley